Become a Founder Member Now!

Utah cannabis program reduces opioid use by 53 percent

October 15, 2024 | Utah Interim, Utah Legislative Branch, Utah


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Utah cannabis program reduces opioid use by 53 percent
In a recent government meeting, officials discussed significant changes to Utah's medical cannabis program, focusing on enhancing accessibility and efficiency. The meeting highlighted plans to relocate operations to the Center for Medical Cannabis Research (CMCR) at the University of Utah, aiming to leverage improved infrastructure.

One of the key proposals includes adding a seat to the policy advisory board for the CMCR, inviting stakeholders to engage in discussions about the evolving landscape of medical cannabis licensing. The Utah Department of Agriculture and Food (UDAF) is also set to address outdated language in the state’s central patient portal, ensuring patients can view essential product information before purchasing, potentially through more efficient methods like QR codes.

A major topic of discussion was the need for clearer advertising regulations for cannabis processors. This change is expected to provide patients with better access to product information and pricing, particularly for processors that do not operate pharmacies.

The meeting also featured testimony from industry representatives, including the chief growth officer of Dragonfly, who emphasized the positive impact of the medical cannabis program on reducing opioid use among patients. A recent analysis indicated that 84% of patients with chronic pain have decreased their opioid consumption since the program's inception in 2019, contributing to a notable decline in opioid-related deaths in the state.

To further enhance the program, industry advocates called for legislative support in four key areas: authorizing telemedicine for medical cannabis recommendations, easing advertising restrictions, expanding qualifying conditions for medical cannabis, and addressing tax issues related to cannabis sales.

These discussions reflect a concerted effort to improve the medical cannabis framework in Utah, aiming to provide safer alternatives for patients while addressing the ongoing opioid crisis. Stakeholders are encouraged to participate in the legislative process to ensure that the program remains accessible and effective for all Utahns.

View full meeting

This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.

View full meeting

Sponsors

Proudly supported by sponsors who keep Utah articles free in 2025

Excel Chiropractic
Excel Chiropractic
Scribe from Workplace AI
Scribe from Workplace AI